Andrew Alyao Ocero is the Director of Clinical Services on JSI’s Northern Uganda Malaria AIDS and Tuberculosis (NUMAT) Program. In this blog, Dr. Ocero calls Rome a theatrical backdrop to the IAS 2011 conference’s grand three day performance, where findings of landmark clinical trials were put on show, studies were debated, and challenges and innovations were hashed out. He and fellow participating NUMAT staff noted the clear message that implementation science needs to become part and parcel of strategies aimed at strengthening health service delivery, took away a greater appreciation of the ways stronger referral mechanisms and more comprehensive MCH and FP services can attract more HIV clients to use services, and were given pause by two papers presented at the conference which put a caveat on assumptions about service integration as a panacea for improved HIV care.
In my community, youth are still unable to access youth-friendly HIV services. I believe communities like mine can empower HIV-positive youth who choose to be open about their HIV status by providing self-esteem training; supporting them to establish youth-centered positive prevention clubs; educating them on condom use, then making protection supplies available; and finally by linking them to existing youth centers and youth organizations to access reproductive health and HIV services.
The recent unprecedented investment in combating the HIV pandemic by United States President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria have led to the debate on whether HIV programs have strengthened or undermined national health systems in developing countries. The debate was continued by health system strengthening (HSS) … Continue reading “Health systems strengthening: The dichotomy between HIV and non-HIV services”
What is the lesson learned from this new evidence? Probably, our programs will see more and more frequently the use of CD4 count tests, depending on various national policies and the different degree of compliance with the WHO guidelines. We need to be ready to incorporate this element into our activities that are related to HIV care and treatment. Additionally, we may look into possible alternative options to implement the provision of CD4 tests.
The proceedings at the 18th International Conference on AIDS in Vienna on Wednesday and Thursday had particularly resounding relevance to some of the work the clinical department at the JSI – NUMAT project has hitherto been engaged in. On Wednesday, we were given an opportunity to showcase our largely successful effort to provide CD4 lymphocyte … Continue reading “ART Laboratory Monitoring”
There is still something missing in the monitoring of TB/HIV activities that would be worth collecting. TB and both ART and pre-ART patients are currently being assessed in cohorts and their outcome measured according to standardized categories. However, little is known about the outcome of co-infected individuals, since their details get mixed with the overall cohort they belong to.
our programs should nonetheless endeavor to gather as much data on other aspects of care as possible and to find time for elaborating and analyzing more health information. This could produce two essential results. First, by doing so we should be able to look at the broader picture of our intervention as far as health care services are concerned. Secondly, we could be more informed and authoritative in documenting our findings, supporting our views, and contributing to the design of future programs.